On August 9, 2011, UNIVEC issued an official press release
On August 9, 2011, UNIVEC issued an official press release titled "UNIVEC Announces FDA Labeler Code Approval" After 24==months under FDA guidelines, an assigned labeler code that does not have any active, commercialized drug products listed under it will eventually be marked inactive by the agency....getting an FDA Labeler Code is the mandatory first step to creating a National Drug Code (NDC).
Why hasn't Dalton.....Secured a new FDA Labeler Code as its an inexpensive administrative step???
If the Reliefta Patch is marketed or framed as a prescription neuro-anesthetic patch, it legally crosses into prescription drug territory. In that scenario, it cannot be legally sold, distributed, or e-prescribed without:
1. An approved FDA NDA or ANDA.
2. Processing through a state-licensed pharmacy with a licensed pharmacist.
The FDA requires human clinical trial data before granting full approval. Bypassing human trials only happens under strict emergency provisions or special regulatory pathways like the Animal Rule.
Researched every major trial databases—including the National Institutes of Health (NIH) ClinicalTrials.gov registry, the FDA database, PubMed, and medical literature—yields zero clinical trials conducted on or registered for a product named "RELIEFTA" by Haygood Farms, UNIVEC, or 11 Three LLC, CentennialRx.
If anyone knows where else to research to find the trials, please post the links....
PL
2
1
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Mission Rock Residential's Commitment to Resident Well-Being Transforming Communities Through Effective Management Mission Rock Residential California, Inc. (MRC) has dedicated itself to restoring stability, safety, and trust for countless residents, especially those who faced years of neglect under a prior ownership structure. The previous management not only failed to...
Continue Reading
Understanding the Recent Market Movements of Amgen High-profile investors are showing a bullish stance on Amgen (NASDAQ: AMGN), making it essential for retail traders to pay attention. This interest largely stems from tracking of options data, which reveals substantial activity around Amgen's stock, often indicative of informed decision-making by key players. Options...
Continue Reading
TC Energy Announces Impressive Q2 2025 Results TC Energy Corporation (TSX, NYSE: TRP) has shared its strong financial performance for the second quarter of 2025, affirming the company’s commitment to operational excellence. François Poirier, the President and CEO of TC Energy, highlighted the impressive financial outlook, stating that the comparable EBITDA for the year...
Continue Reading
Understanding the Growth of the Digital Folding Cartons Market The global digital folding cartons market is on a trajectory for substantial growth. Currently estimated at USD 13.3 billion, it is projected to escalate to USD 24.3 billion by 2035, with a compound annual growth rate (CAGR) of 6.2% during the forecast period. Key Drivers of Market Expansion As brands evolve,...
Continue Reading
Gardening Trends to Embrace in 2025 As we approach 2025, gardening enthusiasts are gearing up for a year filled with vibrant colors and unique plant selections. Calloway's Nursery has unveiled the top five gardening trends that promise to transform indoor and outdoor spaces. Jennifer Hatalski, Vice President of Calloway's Nursery, shares her insights on what to expect in...
Continue Reading